ATE203513T1 - Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung - Google Patents

Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung

Info

Publication number
ATE203513T1
ATE203513T1 AT96928647T AT96928647T ATE203513T1 AT E203513 T1 ATE203513 T1 AT E203513T1 AT 96928647 T AT96928647 T AT 96928647T AT 96928647 T AT96928647 T AT 96928647T AT E203513 T1 ATE203513 T1 AT E203513T1
Authority
AT
Austria
Prior art keywords
compounds
inflammatory
inhibiting
methods
reverse transcriptase
Prior art date
Application number
AT96928647T
Other languages
English (en)
Inventor
Farid Hamedi-Sangsari
Fabienne Nugier
Thierry Vallet
Jacques Grange
Jorge Vila
Original Assignee
Cie De Dev Aguettant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cie De Dev Aguettant filed Critical Cie De Dev Aguettant
Application granted granted Critical
Publication of ATE203513T1 publication Critical patent/ATE203513T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96928647T 1995-09-15 1996-09-13 Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung ATE203513T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52887995A 1995-09-15 1995-09-15
US08/600,525 US5705522A (en) 1995-09-15 1996-02-13 Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
PCT/IB1996/000942 WO1997010205A1 (en) 1995-09-15 1996-09-13 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same

Publications (1)

Publication Number Publication Date
ATE203513T1 true ATE203513T1 (de) 2001-08-15

Family

ID=27062862

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928647T ATE203513T1 (de) 1995-09-15 1996-09-13 Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung

Country Status (8)

Country Link
US (1) US5705522A (de)
EP (1) EP0854860B1 (de)
JP (1) JP2000511871A (de)
AT (1) ATE203513T1 (de)
AU (1) AU6835096A (de)
CA (1) CA2231996A1 (de)
DE (1) DE69614127D1 (de)
WO (1) WO1997010205A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4716299A (en) * 1998-06-24 2000-01-10 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
NZ521210A (en) * 2000-02-18 2004-11-26 Shire Biochem Inc Method for the treatment or prevention of flavivirus infections using nucleoside analogues
US20050087555A1 (en) * 2003-10-28 2005-04-28 Hatton Jason D. Fluid dispensing components
KR101423898B1 (ko) * 2005-12-14 2014-07-28 암브룩스, 인코포레이티드 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE108794T1 (de) * 1985-05-15 1994-08-15 Wellcome Found Therapeutische nucleoside und deren herstellung.
US5254539A (en) * 1985-08-26 1993-10-19 U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health Method of treating HIV with 2',3'-dideoxyinosine
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
FR2646348A1 (fr) * 1989-04-28 1990-11-02 Inst Nat Sante Rech Med D-aspartique acide-hydroxamate en tant que medicament
US5571839A (en) * 1989-04-28 1996-11-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) D-aspartic acid β-hydroxamate for the treatment of viral infections and tumors
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
ATE273700T1 (de) * 1993-05-21 2004-09-15 Us Gov Health & Human Serv Neues verfahen zur hemmung der replication der virus - abhängigen reverse transciptase durch verwendung von dideoxydenucleotide-synthese inhibitoren
WO1995017875A2 (en) * 1993-12-20 1995-07-06 Compagnie De Developpement Aguettant MIXTURES OF DIDEOXYNUCLEOSIDES AND D-ASPARTIC ACID β-HYDROXAMATE FOR INHIBITING RETROVIRAL SPREAD

Also Published As

Publication number Publication date
US5705522A (en) 1998-01-06
AU6835096A (en) 1997-04-01
DE69614127D1 (de) 2001-08-30
EP0854860B1 (de) 2001-07-25
EP0854860A1 (de) 1998-07-29
CA2231996A1 (en) 1997-03-20
WO1997010205A1 (en) 1997-03-20
JP2000511871A (ja) 2000-09-12

Similar Documents

Publication Publication Date Title
DK0735890T3 (da) Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning
DE3587434D1 (de) Antivirale pharmazeutische zusammensetzungen und ihrer verwendung.
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
MX9700237A (es) Combinaciones inhibidoras de proteasa retroviral.
DK282585D0 (da) Synergistiske blandinger af interferoner og tumor-nekrose-faktor
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
ATE227133T1 (de) Verwendung von interferon-alpha 8 subtype zur herstellung von medikamenten zur behandlung von viralinfektionen der leber
DE60022380D1 (de) Verwendung von einem trifluridin derivat allein oder in kombination mit einem thymidin-phosphorylase-hemmer zur behandlung von hiv
DE3780016T2 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin-2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
DE60036862D1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid-analoge
ATE203513T1 (de) Eine familie von verbindungen mit entzündungshemmender und antiviraler aktivität und deren zusammensetzungen alleine oder in verbindung mit inhibitoren der reversen transcriptase zur inhibierung, vermeidung oder eliminierung viraler replikation und methoden zu ihrer verwendung
ES2113888T3 (es) Sulfatos de dextrina como agentes anti hiv-1 y composicion de los mismos.
DE69403063T2 (de) Gegen viren wirksame naphtochinon-verbindungen, zusammensetzungen und deren verwendungen
DE69232417D1 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
ES2134259T3 (es) Compuestos antiviricos calanolidas, composiciones y utilizacion de los mismos.
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
AR011586A1 (es) Agentes antivirales derivados del 6-bencil-1-etoximetil-5-uracilo sustituido y su uso para el tratamiento de infecciones virales
NO934528L (no) Acylerte hepariner som inhibitorer for replikasjonen av retrovirus
ATE114115T1 (de) Verwendung von 5,6-dihydro-dibenz(b,e>azepin-6,11-dion-11-oxim n zur herstellungvon antiretroviralen mitteln.
ATE119392T1 (de) Spezifischer produktinhibitor der retroviralen reversen transkriptase und seine verwendung als arzneimittel.
Devi et al. Clastogenic effect of WR-2721 on mouse chromosomes
ATE179601T1 (de) Aufheben der resistenz von hiv-1 linien gegenüber zidovudine
DE68929084D1 (de) Arzneimittel zur Verhinderung einer Infektion mit dem für AIDS verantwortlichen Virus
SE8106621L (sv) Lekemedel med aktivitet mot orosneuros och orosliknande neuros och forfarande for framstellning derav

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties